AMSTERDAM, April 30 /PRNewswire/ -- SynCo Bio Partners B.V. (Amsterdam, The Netherlands), the cGMP manufacturer of clinical and commercial biopharmaceuticals, has won the Vaccine Industry Excellence (ViE) award for Best Contract Manufacturing Organization (CMO) 2009. This award was presented to SynCo at the Washington World Vaccine Congress on the 22nd of April and is a recognition of the excellent work by SynCo's scientists and manufacturing staff on behalf of its clients over the last 9 years.
SynCo was nominated by a panel of judges from the industry and selected over 5 other finalists in the Best CMO category, according to a wide range of criteria including:
- The range of services provided in niche and core therapeutic areas - Methods of performance improvement or introduction of new services - Attention to and quality of relationships with clients - Reaching of milestones and final / ongoing outcomes - Building and maintaining existing and long term partnerships
Pierre Warffemius, CEO, said 'this award endorses SynCo's aim to be the long term strategic choice of biotechnology companies for the development of production processes and the GMP manufacture of protein, live-microbial, polysaccharide and monoclonal antibody-based biopharmaceuticals."
Issued on behalf of SynCo Bio Partners by De Facto Communications For more information, contact:
About SynCo Bio Partners B.V.
SynCo Bio Partners is a GMP-licensed bulk drug substance and final
product CMO with in-depth clinical and commercial production experience with
mammalian and microbial systems. This experience has been acquired by
developing new production processes for a number of international clients and
producing a wide variety of different vaccines, live bacterial products and
recombinant proteins in our state-of-the-art, GMP-licensed facilities since
|SOURCE SynCo Bio Partners B.V.|
Copyright©2009 PR Newswire.
All rights reserved